Affiris AG

scout_1 Posted On August 1, 2014

9 Views

Share On Facebook
Tweet It

The AFFITOME® technology from AFFiRiS delivers innovative vaccines for therapeutic treatment of chronic diseases with unmet medical need and attractive markets.

Post Views: 9

Share On Facebook
Tweet It

Author

scout_1

Trending Now

Helsinki to host over 600 investors across 3 startup events in 2019

Tim Hinchliffe November 7, 2018

Meet the 17 Dutch social entrepreneurs heading to SOCAP in San Francisco

Tim Hinchliffe October 19, 2018

Affiris AG

scout_1

Trending Now

Helsinki to host over 600 investors across 3 startup events in 2019

Meet the 17 Dutch social entrepreneurs heading to SOCAP in San Francisco

Akron Molecules

Leave A Reply

Leave a Reply Cancel reply

Affiris AG

Recent Posts